IN2012DN00977A - - Google Patents
Info
- Publication number
- IN2012DN00977A IN2012DN00977A IN977DEN2012A IN2012DN00977A IN 2012DN00977 A IN2012DN00977 A IN 2012DN00977A IN 977DEN2012 A IN977DEN2012 A IN 977DEN2012A IN 2012DN00977 A IN2012DN00977 A IN 2012DN00977A
- Authority
- IN
- India
- Prior art keywords
- diabetes
- type
- postprandial hyperglycemia
- spot treatment
- dosage
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
Abstract
The invention provides a method and a pharmaceutical composition in the form of a hydroalcoholic solution in which at least one hypoglycemia-inducing/insulinotropic active principle is dissolved in a stable and complete manner at a dosage that is reduced by 3 0% to 50% compared with the usual oral unit dosage, for its trans-buccal mucosal application in the spot treatment of postprandial hyperglycemia in type II diabetes in man or animals. The invention also pertains to a method of preparing said formulation and to its specific use in the spot treatment of postprandial hyperglycemia (PPHG) in the context of type II diabetes.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0954819A FR2947729B1 (en) | 2009-07-10 | 2009-07-10 | PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF TYPE II DIABETES BY ORAL TRANS-MUCOSAL METHOD |
PCT/FR2010/051426 WO2011004117A1 (en) | 2009-07-10 | 2010-07-07 | Method and pharmaceutical compositions for trans-buccal mucosa treatment of postprandial hyperglycaemia in type ii diabetes |
Publications (1)
Publication Number | Publication Date |
---|---|
IN2012DN00977A true IN2012DN00977A (en) | 2015-04-10 |
Family
ID=41571558
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IN977DEN2012 IN2012DN00977A (en) | 2009-07-10 | 2010-07-07 |
Country Status (10)
Country | Link |
---|---|
US (1) | US9161910B2 (en) |
EP (1) | EP2451436A1 (en) |
JP (1) | JP2012532852A (en) |
CN (1) | CN102481254A (en) |
BR (1) | BR112012000596A2 (en) |
FR (1) | FR2947729B1 (en) |
IN (1) | IN2012DN00977A (en) |
MX (1) | MX337606B (en) |
RU (1) | RU2543635C2 (en) |
WO (1) | WO2011004117A1 (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2940116B1 (en) * | 2008-12-22 | 2012-07-06 | Philippe Perovitch | FORMULATION FOR THE ADMINISTRATION OF HYPOLIPEMIC BY ORAL TRANS-MUCOSAL |
FR3000896B1 (en) * | 2013-01-14 | 2016-08-26 | Philippe Perovitch | GALENIC FORM FOR ADMINISTRATION OF ACTIVE INGREDIENT (S) FOR ACCELERATED INDUCTION OF SLEEP AND / OR TREATMENT OF SLEEP DISORDERS |
FR3031668A1 (en) | 2015-01-20 | 2016-07-22 | Philippe Perovitch | DEVICE FOR DELIVERY OF ACTIVE PRINCIPLE BY PERMUCOSAL MOUTH. |
FR3053244A1 (en) | 2016-07-01 | 2018-01-05 | Philippe Perovitch | DEVICE FOR DELIVERY OF AT LEAST ONE ACTIVE PRINCIPLE BY PERMUCOSAL MOUTH. |
CN107669683B (en) * | 2017-09-30 | 2020-07-03 | 杭州华东医药集团新药研究院有限公司 | Pharmaceutical composition containing sitagliptin and metformin |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2071779C1 (en) * | 1993-05-12 | 1997-01-20 | Хабаровский химико-фармацевтический завод | Method of preparing pantocrin for injection |
US20030095925A1 (en) * | 1997-10-01 | 2003-05-22 | Dugger Harry A. | Buccal, polar and non-polar spray or capsule containing drugs for treating metabolic disorders |
US6451286B1 (en) * | 1998-12-21 | 2002-09-17 | Generex Pharmaceuticals Incorporated | Pharmaceutical compositions for buccal and pulmonary administration comprising an alkali metal alkyl sulfate and at least three micelle-forming compounds |
US20030087820A1 (en) * | 1999-01-14 | 2003-05-08 | Young Andrew A. | Novel exendin agonist formulations and methods of administration thereof |
US20030235595A1 (en) * | 1999-06-30 | 2003-12-25 | Feng-Jing Chen | Oil-containing, orally administrable pharmaceutical composition for improved delivery of a therapeutic agent |
US7411089B2 (en) * | 2002-04-15 | 2008-08-12 | Ajinomoto Co., Inc. | Nateglinide crystals |
SE528866C2 (en) * | 2005-07-01 | 2007-02-27 | Volvo Lastvagnar Ab | Apparatus for controlling the height of a load or load carrier behind the cab of a truck |
US7834012B2 (en) * | 2005-08-30 | 2010-11-16 | Abbott Laboratories | Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-IV (DPP-IV) |
DE102006027790A1 (en) * | 2006-06-16 | 2007-12-20 | Lts Lohmann Therapie-Systeme Ag | Type 2 diabetes combination wafers |
JP2009544715A (en) * | 2006-07-28 | 2009-12-17 | ノヴァデル ファーマ インコーポレイテッド | Oral spray formulation and method for anti-migraine |
FR2906140B1 (en) * | 2006-09-22 | 2008-12-05 | Philippe Perovitch | GALENIC FORM FOR TRANSMUCOSUS ADMINISTRATION OF ACTIVE INGREDIENTS |
-
2009
- 2009-07-10 FR FR0954819A patent/FR2947729B1/en not_active Expired - Fee Related
-
2010
- 2010-07-07 WO PCT/FR2010/051426 patent/WO2011004117A1/en active Application Filing
- 2010-07-07 MX MX2012000466A patent/MX337606B/en active IP Right Grant
- 2010-07-07 BR BR112012000596A patent/BR112012000596A2/en not_active IP Right Cessation
- 2010-07-07 CN CN2010800381696A patent/CN102481254A/en active Pending
- 2010-07-07 EP EP10742210A patent/EP2451436A1/en not_active Withdrawn
- 2010-07-07 JP JP2012519040A patent/JP2012532852A/en active Pending
- 2010-07-07 RU RU2012104639/15A patent/RU2543635C2/en not_active IP Right Cessation
- 2010-07-07 US US13/383,101 patent/US9161910B2/en not_active Expired - Fee Related
- 2010-07-07 IN IN977DEN2012 patent/IN2012DN00977A/en unknown
Also Published As
Publication number | Publication date |
---|---|
RU2012104639A (en) | 2013-08-20 |
US20120190618A1 (en) | 2012-07-26 |
FR2947729A1 (en) | 2011-01-14 |
MX337606B (en) | 2016-03-10 |
US9161910B2 (en) | 2015-10-20 |
WO2011004117A1 (en) | 2011-01-13 |
RU2543635C2 (en) | 2015-03-10 |
MX2012000466A (en) | 2012-04-19 |
EP2451436A1 (en) | 2012-05-16 |
BR112012000596A2 (en) | 2016-02-10 |
JP2012532852A (en) | 2012-12-20 |
FR2947729B1 (en) | 2012-01-20 |
CN102481254A (en) | 2012-05-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TN2011000437A1 (en) | Substituted azoanthracene derivatives, pharmaceutical compositions, and methods of use thereof | |
CY1119582T1 (en) | HYDRAULIC INSULIN PREPARATIONS CONTAINING Methionine | |
EA201491934A1 (en) | GLUCAGON-LIKE PEPTIDE-2 ANALOGES (GLP-2) | |
PE20130511A1 (en) | LONG-ACTING INSULIN FORMULATIONS | |
EA201491060A1 (en) | NEW DERIVATIVES OF TRIFTOROMETHYLOROXIAZOLE AND THEIR APPLICATION FOR THE TREATMENT OF DISEASE | |
BR112015013809A2 (en) | exendin-4 derivatives as glp1 / gip double agonists or glp1 / gip / lucagon trigonals, their use and pharmaceutical composition | |
NO20084919L (en) | oxadiazolidinedione | |
EA201490521A1 (en) | OPTIONS OF FIBROBLAST GROWTH FACTOR 21 | |
CY1117603T1 (en) | LIXISENATIDE AS AN ADDITION TO METFORMIN IN THE TREATMENT OF TYPE 2 DIABETES | |
CL2008000198A1 (en) | COMPOUNDS DERIVED FROM AZACICLOALCANOS, INHIBITORS FROM ESTEAROIL-COENZIMA TO DELTA-9; PHARMACEUTICAL COMPOSITION; AND USE FOR THE TREATMENT OF SICK DISEASES AS TYPE 2 DIABETES, LIPID DISORDER, OBESITY AND ATEROSCLEROSIS. | |
CL2009001340A1 (en) | Composed of pegylated insulin lispro or a salt thereof comprising a chain a of sec no: 1, a chain b of sec no: 3 and the peg is of a weight between 20 to 40 kda; use of said compound to treat hypoglycemia or diabetes; pharmaceutical composition comprising said compound; and process for making said compound. | |
EA201100691A1 (en) | ANTAGONISTS OF LYSOPHPATIDIC ACID RECEPTORS | |
UA96441C2 (en) | Pharmaceutical composition comprosing thiazolidinedione analogues for the treatment of metabolic inflammation mediated disease | |
EA201290964A1 (en) | Peptide Conjugates of GLP-1 Receptor Agonists and Their Use | |
MX2009011359A (en) | Pyrimidinone derivatives and methods of use thereof. | |
EA201290078A1 (en) | HETEROCYCLIC COMPOUNDS TO INHIBIT PASK | |
EP2415749A4 (en) | New salvianolic acid compound l, preparation method and use thereof | |
NZ608829A (en) | Pharmaceutical composition comprising an sglt2-inhibitor, methods for treating and uses thereof | |
CL2007001886A1 (en) | Compounds derived from piperidine or pyrrolidine ureas; preparation procedure; pharmaceutical composition; and its use as modulators of the activity of 11ß-hydroxysteroid dehydrogenase type 1 (11ßhsd1) to treat obesity, diabetes, insulin resistance, cushing syndrome and hypertension, among others. | |
EA201070477A1 (en) | TRANS-CLOMIFEN FOR THE TREATMENT OF METABOLIC SYNDROME | |
MX2012006734A (en) | Ppar-sparing thiazolidinediones and combinations for the treatment of obesity and other metabolic diseases. | |
WO2008084504A3 (en) | Pharmaceutical compositions of angiotensin ii receptor blockers | |
IN2012DN00977A (en) | ||
MX2017004614A (en) | Composite preparation, containing novel 3-(4-(benzyloxy)phenyl)he x-4-inoic acid derivative and another active ingredient, for preventing or treating metabolic diseases. | |
MX2015014007A (en) | TREATMENT OF DIABETES MELLITUS BY LONGâACTING FORMULATIONS OF INSULINS. |